An Updated Approach to the Diagnosis and Management of Enteric Fever in Clinical Practice

Introduction

Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health issue. Despite advancements in diagnostic methods and treatment strategies, challenges persist. This article aims to provide an updated approach to the diagnosis and management of enteric fever in clinical practice.

Diagnostic Methods

Diagnosis of enteric fever relies on clinical suspicion, backed by laboratory confirmation. Blood culture remains the gold standard, with sensitivity rates of 40-60%. However, its utility is limited by the need for specialized laboratory facilities and delayed results. Recent advancements include rapid diagnostic tests (RDTs) based on detection of specific antigens or antibodies. These offer the advantage of providing results within hours, but their sensitivity and specificity vary widely.

Antibiotic Therapy

Treatment of enteric fever relies primarily on antibiotic therapy. However, the increasing incidence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains poses a significant challenge. Current guidelines recommend the use of third-generation cephalosporins or fluoroquinolones in regions with high rates of resistance. However, fluoroquinolones should be avoided in children due to potential side effects. In the case of XDR strains, newer antibiotics such as azithromycin and carbapenems may be considered.

Vaccination

Vaccination remains a crucial component of enteric fever prevention. Two vaccines are currently available: the oral live-attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine. Both have demonstrated efficacy, but neither provides complete protection. The development of new vaccines, particularly conjugate vaccines, offers promise for improved prevention strategies.

Conclusion

In conclusion, the diagnosis and management of enteric fever continue to evolve with advancements in diagnostic methods, the emergence of antibiotic resistance, and developments in vaccination. Clinicians must remain updated on these changes to ensure effective management and control of this significant global health issue.